Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 2/20 | 0.59 |
| ▸ | FNTA | P49354 | 14/20 | 0.42 |
| ▸ | FNTB | P49356 | 12/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337255 | 1.00 | BTN3A1 (0.59) | BTN3A1FNTAFNTBPGGT1BTSHR | |
| SCHEMBL27707012 | 0.91 | TSHR (0.56) | BTN3A1FNTAFNTBPGGT1BTSHR | |
| SCHEMBL153576 | 0.90 | BTN3A1 (0.61) | BTN3A1FNTAFNTBPGGT1B | |
| Water SCHEMBL23780676 | 0.88 | BTN3A1 (0.59) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL27197526 | 0.84 | BTN3A1 (0.71) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL21576850 | 0.83 | BTN3A1 (0.53) | BTN3A1FNTAFNTBPGGT1BTSHR | |
| SCHEMBL17140229 | 0.82 | BTN3A1 (0.69) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL21571159 | 0.82 | BTN3A1 (0.76) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL1004250 | 0.82 | BTN3A1 (0.69) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL3099412 | 0.81 | FNTA (0.66) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023104046-A1 | RECOMBINANT STRAIN CONTAINING ISOPRENOID ALCOHOL KINASE GENE AND ISOPENTENYL PHOSPHATE KINASE GENE, AND APPLICATION OF RECOMBINANT STRAIN IN PRODUCTION OF TERPENOIDS | 深圳先进技术研究院 | 2023-06-15 | — | — | WO | claimed |
| WO-2023006699-A1 | CELLS AND METHOD FOR PRODUCING ISOPRENOID MOLECULES WITH CANONICAL AND NON-CANONICAL STRUCTURES | Københavns Universitet (DK) | 2023-02-02 | — | — | WO | claimed |
| CN-115605589-A | Improved process for the production of isoprenoids | 巴斯夫欧洲公司（DE） | 2023-01-13 | — | — | CN | claimed |
| CN-108779477-B | Method for producing isobutene from 3-methylcrotonyl-CoA | 环球生物能源公司 | 2022-12-13 | — | — | CN | claimed |
| CN-115003823-A | Biosynthetic platform for the production of cannabinoids and other prenylated compounds | 加利福尼亚大学董事会 | 2022-09-02 | — | — | CN | claimed |
| CN-114410675-A | Recombinant strain containing enol kinase gene and isopentenyl phosphate kinase gene and application thereof in production of terpenoid | 深圳先进技术研究院 | 2022-04-29 | — | — | CN | claimed |
| US-20220127649-A1 | ENGINEERED CELLS FOR IMPROVED PRODUCTION OF CANNABINOIDS | CREO INGREDIENTS, INC. | 2022-04-28 | — | — | US | claimed |
| US-11124806-B2 | Methods for producing isobutene from 3-methylcrotonic acid | GLOBAL BIOENERGIES (FR) | 2021-09-21 | — | — | US | claimed |
| CN-107075530-B | Method for producing isobutene from 3-methylcrotonyl-CoA | 环球生物能源公司 | 2021-06-01 | — | — | CN | claimed |
| EP-3433370-B1 | ENZYMATIC METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLBUTYRIC ACID | GLOBAL BIOENERGIES (FR) | 2020-04-29 | — | — | EP | claimed |
| CN-110869487-A | Metabolic engineering for microbial production of terpenoid products | 马努斯生物合成股份有限公司 | 2020-03-06 | — | — | CN | claimed |
| US-20190112620-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | GLOBAL BIOENERGIES (FR) | 2019-04-18 | — | — | US | claimed |
| EP-3433370-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | Global Bioenergies (FR) | 2019-01-30 | — | — | EP | claimed |
| US-20180371503-A1 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2018-12-27 | — | — | US | claimed |
| EP-3377639-A2 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | Global Bioenergies (FR) | 2018-09-26 | — | — | EP | claimed |
| WO-2017162738-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | GLOBAL BIOENERGIES (FR) | 2017-09-28 | — | — | WO | claimed |
| US-20170260548-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | Scientist of Fortune, S.A. (LU) | 2017-09-14 | — | — | US | claimed |
| EP-3194603-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-CoA | Global Bioenergies (FR) | 2017-07-26 | — | — | EP | claimed |
| WO-2016042011-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-CoA | GLOBAL BIOENERGIES (FR) | 2016-03-24 | — | — | WO | claimed |
| US-12497635-B2 | Means and methods for producing isobutene from acetyl-CoA | GLOBAL BIOENERGIES (FR) | 2025-12-16 | — | — | US | disclosed |
| US-20250327097-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2025-10-23 | — | — | US | disclosed |
| US-12428628-B2 | Recombinant production of steviol glycosides | DANSTAR FERMENT AG (CH) | 2025-09-30 | — | — | US | disclosed |
| US-20250027131-A1 | RECOMBINANT PRODUCTION OF STEVIOL GLYCOSIDES | DANSTAR FERMENT AG (CH) | 2025-01-23 | — | — | US | disclosed |
| CN-113614240-B | Improved means and methods for producing isobutene from acetyl-CoA | 环球生物能源公司 | 2024-12-13 | — | — | CN | disclosed |
| US-12146177-B2 | Methods of making and using E,Z,E-geranylgeranyl diphosphate | WISYS TECHNOLOGY FOUNDATION, INC. (US) | 2024-11-19 | — | — | US | disclosed |
| US-20240344094-A1 | METHODS AND COMPOSITIONS USEFUL FOR THE PRODUCTION OF OLEFINIC ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-17 | — | — | US | disclosed |
| US-12084704-B2 | Methods for producing isobutene from 3-methylcrotonic acid | GLOBAL BIOENERGIES (FR) | 2024-09-10 | — | — | US | disclosed |
| CN-117867044-B | Biological enzyme method preparation technology of vitamin MK-4 | 杭州微远生物科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| EP-4399284-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | Global Bioenergies (FR) | 2024-07-17 | — | — | EP | disclosed |
| CN-110914441-B | Improved process for producing isobutene from 3-methylcrotonic acid | 环球生物能源公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-117980473-A | Organisms producing less crotonic acid | 环球生物能源公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117867044-A | Biological enzyme method preparation technology of vitamin MK-4 | 杭州微远生物科技有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20240110215-A1 | Recombinant Production of Steviol Glycosides | DANSTAR FERMENT AG (CH) | 2024-04-04 | — | — | US | disclosed |
| EP-3622080-B1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2024-03-27 | — | — | EP | disclosed |
| WO-2024052465-A1 | INTERACTION BETWEEN A GLYCOLIPID AND MAJOR CAPSID PROTEIN (VP1) OF SHEEP POLYOMAVIRUS AND, METHODS, KITS AND USES THEREOF | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4335865-A1 | INTERACTION BETWEEN A GLYCOLIPID AND MAJOR CAPSID PROTEIN (VP1) OF SHEEP POLYOMAVIRUS AND, METHODS, KITS AND USES THEREOF | Eberhard-Karls-Universität Tübingen (DE) | 2024-03-13 | — | — | EP | disclosed |
| US-20240002422-A1 | Glycan Analysis and Profiling | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20230258563-A1 | DETECTION OF VOLATILES | ISOBIONICS B V (NL) | 2023-08-17 | — | — | US | disclosed |
| US-20230225972-A1 | LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION | STATENS SERUM INSTITUT (DK) | 2023-07-20 | — | — | US | disclosed |
| WO-2023104046-A1 | RECOMBINANT STRAIN CONTAINING ISOPRENOID ALCOHOL KINASE GENE AND ISOPENTENYL PHOSPHATE KINASE GENE, AND APPLICATION OF RECOMBINANT STRAIN IN PRODUCTION OF TERPENOIDS | 深圳先进技术研究院 | 2023-06-15 | — | — | WO | disclosed |
| US-20230174922-A1 | MODIFIED YEAST HOST CELLS USEFUL FOR PRODUCING ISOPRENOL | UNITED STATES DEPARTMENT OF ENERGY | 2023-06-08 | — | — | US | disclosed |
| EP-4179067-A1 | MODIFIED YEAST HOST CELLS USEFUL FOR PRODUCING ISOPRENOL | The Regents of University of California (US) | 2023-05-17 | — | — | EP | disclosed |
| WO-2023077017-A1 | METHODS AND COMPOSITIONS USEFUL FOR THE PRODUCTION OF OLEFINIC ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023031482-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2023-03-09 | — | — | WO | disclosed |
| EP-4144838-A1 | ORGANISMS PRODUCING LESS CROTONIC ACID | Global Bioenergies (FR) | 2023-03-08 | — | — | EP | disclosed |
| EP-4135653-A1 | LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION | Statens Serum Institut (DK) | 2023-02-22 | — | — | EP | disclosed |
| CN-115698272-A | Production of geranyl diphosphate derived compounds | 哥本哈根大学 | 2023-02-03 | — | — | CN | disclosed |
| WO-2023006699-A1 | CELLS AND METHOD FOR PRODUCING ISOPRENOID MOLECULES WITH CANONICAL AND NON-CANONICAL STRUCTURES | Københavns Universitet (DK) | 2023-02-02 | — | — | WO | disclosed |
| CN-115605589-A | Improved process for the production of isoprenoids | 巴斯夫欧洲公司（DE） | 2023-01-13 | — | — | CN | disclosed |
| CN-115515561-A | Liposome composition for preventing or early treating pathogenic infection | 史坦恩斯血清研究所 | 2022-12-23 | — | — | CN | disclosed |
| CN-108779477-B | Method for producing isobutene from 3-methylcrotonyl-CoA | 环球生物能源公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-115038786-A | Optimized tetrahydrocannabinolic acid (THCA) synthase polypeptides | 德美崔克斯公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-115003823-A | Biosynthetic platform for the production of cannabinoids and other prenylated compounds | 加利福尼亚大学董事会 | 2022-09-02 | — | — | CN | disclosed |
| CN-114729337-A | Optimized cannabinoid synthase polypeptides | 德美崔克斯公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-4004538-A1 | DETECTION OF VOLATILES | Isobionics B.V. (NL) | 2022-06-01 | — | — | EP | disclosed |
| US-20220145336-A1 | MEANS AND METHODS FOR PRODUCING ISOBUTENE FROM ACETYL-COA | GLOBAL BIOENERGIES (FR) | 2022-05-12 | — | — | US | disclosed |
| CN-114410675-A | Recombinant strain containing enol kinase gene and isopentenyl phosphate kinase gene and application thereof in production of terpenoid | 深圳先进技术研究院 | 2022-04-29 | — | — | CN | disclosed |
| US-20220127649-A1 | ENGINEERED CELLS FOR IMPROVED PRODUCTION OF CANNABINOIDS | CREO INGREDIENTS, INC. | 2022-04-28 | — | — | US | disclosed |
| EP-3942058-A1 | IMPROVED MEANS AND METHODS FOR PRODUCING ISOBUTENE FROM ACETYL-COA | Global Bioenergies (FR) | 2022-01-26 | — | — | EP | disclosed |
| WO-2022011059-A1 | MODIFIED YEAST HOST CELLS USEFUL FOR PRODUCING ISOPRENOL | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-01-13 | — | — | WO | disclosed |
| US-20210403956-A1 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2021-12-30 | — | — | US | disclosed |
| CN-113614240-A | Improved means and methods for production of isobutene from acetyl-CoA | 环球生物能源公司 | 2021-11-05 | — | — | CN | disclosed |
| WO-2021209562-A1 | LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION | STATENS SERUM INSTITUT (DK) | 2021-10-21 | — | — | WO | disclosed |
| US-11124806-B2 | Methods for producing isobutene from 3-methylcrotonic acid | GLOBAL BIOENERGIES (FR) | 2021-09-21 | — | — | US | disclosed |
| US-20210285016-A1 | METHODS OF MAKING AND USING E,Z,E-GERANYLGERANYL DIPHOSPHATE | WISYS TECHNOLOGY FOUNDATION, INC. | 2021-09-16 | — | — | US | disclosed |
| US-20210277425-A1 | IMPROVED METHODS FOR PRODUCING lSOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2021-09-09 | — | — | US | disclosed |
| CN-107075536-B | Process for producing 3-hydroxy-3-methylbutyric acid | 环球生物能源公司 | 2021-07-02 | — | — | CN | disclosed |
| US-11034980-B2 | Microbial engineering for the production of isoprenoids | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-15 | — | — | US | disclosed |
| CN-107075530-B | Method for producing isobutene from 3-methylcrotonyl-CoA | 环球生物能源公司 | 2021-06-01 | — | — | CN | disclosed |
| WO-2021018782-A1 | DETECTION OF VOLATILES | ISOBIONICS B.V. (NL) | 2021-02-04 | — | — | WO | disclosed |
| US-20210017213-A1 | Glycan Analysis and Profiling | SEATTLE GENETICS, INC. (US) | 2021-01-21 | — | — | US | disclosed |
| WO-2020188033-A1 | IMPROVED MEANS AND METHODS FOR PRODUCING ISOBUTENE FROM ACETYL-COA | GLOBAL BIOENERGIES (FR) | 2020-09-24 | — | — | WO | disclosed |
| EP-2347003-B1 | GALACTOSE ALPHA (1-3) GALACTOSE COMPOSITIONS | JANSSEN BIOTECH INC (US) | 2020-06-10 | — | — | EP | disclosed |
| US-10676765-B2 | Methods for producing 3-hydroxy-3-methylbutyric acid | GLOBAL BIOENERGIES (FR) | 2020-06-09 | — | — | US | disclosed |
| US-20200140912-A1 | Production of Steviol Glycosides in Microorganisms | EVOVLA SA (CH) | 2020-05-07 | — | — | US | disclosed |
| EP-3433370-B1 | ENZYMATIC METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLBUTYRIC ACID | GLOBAL BIOENERGIES (FR) | 2020-04-29 | — | — | EP | disclosed |
| CN-110914441-A | Improved process for the production of isobutene from 3-methylcrotonic acid | 环球生物能源公司 | 2020-03-24 | — | — | CN | disclosed |
| EP-3622080-A1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | Global Bioenergies (FR) | 2020-03-18 | — | — | EP | disclosed |
| CN-110869496-A | Recombinant production system for pentenylated polyketones of the cannabinoid family | 海湾医学公司 | 2020-03-06 | — | — | CN | disclosed |
| EP-3555115-A1 | NOVEL COMPOUNDS AS ANTI-MYCOBACTERIALS | The University Of Sydney (AU) | 2019-10-23 | — | — | EP | disclosed |
| US-10392644-B2 | Production of steviol glycosides in microorganisms | EVOLVA SA (CH) | 2019-08-27 | — | — | US | disclosed |
| EP-2575432-B1 | RECOMBINANT PRODUCTION OF STEVIOL GLYCOSIDES | EVOLVA INC (US) | 2019-08-14 | — | — | EP | disclosed |
| US-20190201340-A1 | METHODS FOR PRODUCING LIPOSOMES | STATENS SERUMINSTITUT (DK) | 2019-07-04 | — | — | US | disclosed |
| US-20190112620-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | GLOBAL BIOENERGIES (FR) | 2019-04-18 | — | — | US | disclosed |
| WO-2018206262-A9 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2019-03-14 | — | — | WO | disclosed |
| US-20190078128-A9 | Production of Steviol Glycosides in Microorganisms | DANSTAR FERMENT AG (CH) | 2019-03-14 | — | — | US | disclosed |
| EP-3433370-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | Global Bioenergies (FR) | 2019-01-30 | — | — | EP | disclosed |
| US-20180371503-A1 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2018-12-27 | — | — | US | disclosed |
| WO-2018206262-A1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2018-11-15 | — | — | WO | disclosed |
| EP-3377639-A2 | METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | Global Bioenergies (FR) | 2018-09-26 | — | — | EP | disclosed |
| WO-2018107236-A1 | NOVEL COMPOUNDS AS ANTI-MYCOBACTERIALS | THE UNIVERSITY OF SYDNEY (AU) | 2018-06-21 | — | — | WO | disclosed |
| EP-2729127-B1 | METHODS FOR PRODUCING LIPOSOMES | STATENS SERUMINSTITUT (DK) | 2018-05-02 | — | — | EP | disclosed |
| US-20180105838-A1 | PROCESS FOR DE NOVO MICROBIAL SYNTHESIS OF TERPENES | BASF SE (DE) | 2018-04-19 | — | — | US | disclosed |
| US-20170305950-A1 | GLYCAN ANALYSIS AND PROFILING | SEATTLE GENETICS, INC. | 2017-10-26 | — | — | US | disclosed |
| WO-2017162738-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | GLOBAL BIOENERGIES (FR) | 2017-09-28 | — | — | WO | disclosed |
| US-20170260548-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-COA | Scientist of Fortune, S.A. (LU) | 2017-09-14 | — | — | US | disclosed |
| US-20170253896-A1 | METHODS FOR PRODUCING 3-HYDROXY-3-METHYLBUTYRIC ACID | GLOBAL BIOENERGIES (FR) | 2017-09-07 | — | — | US | disclosed |
| EP-3204537-A1 | GLYCAN ANALYSIS AND PROFILING | Siamab Therapeutics, Inc. (US) | 2017-08-16 | — | — | EP | disclosed |
| US-20170218419-A1 | Production of Steviol Glycosides in Microorganisms | EVOLVA SA (CH) | 2017-08-03 | — | — | US | disclosed |
| EP-3194605-A1 | METHODS FOR PRODUCING 3-HYDROXY-3-METHYLBUTYRIC ACID | Global Bioenergies (FR) | 2017-07-26 | — | — | EP | disclosed |
| EP-3194603-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-CoA | Global Bioenergies (FR) | 2017-07-26 | — | — | EP | disclosed |
| US-9562251-B2 | Production of steviol glycosides in microorganisms | EVOLVA SA (CH) | 2017-02-07 | — | — | US | disclosed |
| US-20170029454-A1 | NKT CELL LIGANDS AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-02-02 | — | — | US | disclosed |
| US-9476082-B2 | Method of producing isoprenoid compounds in yeast | EVOLVA SA (CH) | 2016-10-25 | — | — | US | disclosed |
| US-9476082-B2 | Method of producing isoprenoid compounds in yeast | EVOLVA SA (CH) | 2016-10-25 | — | — | US | disclosed |
| EP-3049090-A1 | NKT CELL LIGANDS AND METHODS OF USE | The Scripps Research Institute (US) | 2016-08-03 | — | — | EP | disclosed |
| US-9295722-B2 | Bacterial glycolipid activation of CD1d-restricted NKT cells | THE SCRIPPS RESEARCH INSTITUTE (US) | 2016-03-29 | — | — | US | disclosed |
| WO-2016042012-A1 | METHODS FOR PRODUCING 3-HYDROXY-3-METHYLBUTYRIC ACID | GLOBAL BIOENERGIES (FR) | 2016-03-24 | — | — | WO | disclosed |
| WO-2016042011-A1 | METHOD FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONYL-CoA | GLOBAL BIOENERGIES (FR) | 2016-03-24 | — | — | WO | disclosed |
| US-9079962-B2 | Glycosylated specificity exchangers | TRIPEP AB (SE) | 2015-07-14 | — | — | US | disclosed |
| US-8952217-B2 | Process for decreasing verbascose in a plant by expression of a chloroplast-targeted fimD protein | METANOMICS GMBH (DE) | 2015-02-10 | — | — | US | disclosed |
| WO-2014210522-A1 | NKT CELL LIGANDS AND METHODS OF USE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2014-12-31 | — | — | WO | disclosed |
| US-20140325709-A1 | PROCESS FOR THE PRODUCTION OF FINE CHEMICALS | METANOMICS GMBH (DE) | 2014-10-30 | — | — | US | disclosed |
| US-20140205656-A1 | MODIFIED CATIONIC LIPOSOME ADJUVANTS | STATENS SERUM INSTITUT (DK) | 2014-07-24 | — | — | US | disclosed |
| US-8765692-B2 | Modified-galactosyl ceramides for staining and stimulating natural killer T cells | THE SCRIPPS RESEARCH INSTITUTE (US) | 2014-07-01 | — | — | US | disclosed |
| EP-2729127-A2 | METHODS FOR PRODUCING LIPOSOMES | Statens Serum Institut (DK) | 2014-05-14 | — | — | EP | disclosed |
| US-20140112979-A1 | METHODS FOR PRODUCING LIPOSOMES | STATENS SERUM INSTITUT (DK) | 2014-04-24 | — | — | US | disclosed |
| US-20140081004-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS | Knobbe, Martens, Olson & Bear, LLP | 2014-03-20 | — | — | US | disclosed |
| US-8658179-B2 | Glycosylated specificity exchangers | CHRONTECH PHARMA AB (SE) | 2014-02-25 | — | — | US | disclosed |
| US-8603468-B2 | Neutralization of HCV | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2013-12-10 | — | — | US | disclosed |
| US-20130171328-A1 | PRODUCTION OF STEVIOL GLYCOSIDES IN MICROORGANISMS | DANSTAR FERMENT AG (CH) | 2013-07-04 | — | — | US | disclosed |
| US-20130137138-A1 | METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST | DANSTAR FERMENT AG (CH) | 2013-05-30 | — | — | US | disclosed |
| US-20130137138-A1 | METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST | DANSTAR FERMENT AG (CH) | 2013-05-30 | — | — | US | disclosed |
| US-8445288-B2 | Solid-phase detection of terminal monosaccharides cleaved from glycosylated substrates | MERCK PATENT GMBH (DE) | 2013-05-21 | — | — | US | disclosed |
| EP-2575432-A1 | RECOMBINANT PRODUCTION OF STEVIOL GLYCOSIDES | Evolva Nutrition, Inc (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2571991-A1 | METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST | Evolva SA (US) | 2013-03-27 | — | — | EP | disclosed |
| EP-2571991-A1 | METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST | Evolva SA (US) | 2013-03-27 | — | — | EP | disclosed |
| EP-2573188-A2 | Process for the production of fine chemicals | Metanomics GmbH (DE) | 2013-03-27 | — | — | EP | disclosed |
| US-20130041131-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS | CHRONTECH PHARMA AB (SE) | 2013-02-14 | — | — | US | disclosed |
| WO-2013004234-A2 | METHODS FOR PRODUCING LIPOSOMES | STATENS SERUM INSTITUT (DK) | 2013-01-10 | — | — | WO | disclosed |
| US-8303956-B2 | Glycosylated specificity exchangers | CHRONTECH PHARMA AB (SE) | 2012-11-06 | — | — | US | disclosed |
| US-20120270815-A1 | MODIFIED-GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2012-10-25 | — | — | US | disclosed |
| EP-2056842-B1 | MODIFIED-GALACTOSYL CERAMIDE FOR THE TREATMENT OF CANCEROUS DISEASES | SCRIPPS RESEARCH INST (US) | 2012-10-17 | — | — | EP | disclosed |
| US-8277823-B2 | Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids | STATENS SERUM INSTITUT (DK) | 2012-10-02 | — | — | US | disclosed |
| US-8227581-B2 | Modified α-galactosyl ceramides for staining and stimulating natural killer T cells | THE SCRIPPS RESEARCH INSTITUTE (US) | 2012-07-24 | — | — | US | disclosed |
| EP-2052250-B1 | SOLID-PHASE DETECTION OF TERMINAL MONOSACCHARIDES CLEAVED FROM GLYCOSYLATED SUBSTRATES | MERCK PATENT GMBH (DE) | 2012-05-16 | — | — | EP | disclosed |
| WO-2011153378-A1 | Recombinant Production of Steviol Glycosides | ABUNDA NUTRITION, INC. (US) | 2011-12-08 | — | — | WO | disclosed |
| WO-2011146833-A1 | METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST | EVOLVA INC. (US) | 2011-11-24 | — | — | WO | disclosed |
| WO-2011146833-A1 | METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST | EVOLVA INC. (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110287087-A1 | MODIFIED CATIONIC LIPOSOME ADJUVANS | STATENS SERUM INSTITUT (DK) | 2011-11-24 | — | — | US | disclosed |
| EP-2368905-A2 | Process for the control of production of fine chemicals | Metanomics GmbH (DE) | 2011-09-28 | — | — | EP | disclosed |
| US-8017596-B2 | Phosphonates useful as modulators of T-γ-9-δ-2 activity | INNATE PHARMA, S.A. (FR) | 2011-09-13 | — | — | US | disclosed |
| EP-2355798-A1 | MODIFIED CATIONIC LIPOSOME ADJUVANS | Statens Serum Institut (DK) | 2011-08-17 | — | — | EP | disclosed |
| EP-2347003-A1 | GALACTOSE ALPHA (1-3) GALACTOSE COMPOSITIONS | Centocor Ortho Biotech Inc. (US) | 2011-07-27 | — | — | EP | disclosed |
| US-7893253-B2 | Aminating reducing sugar; mass spectrometry | MERCK PATENT GMBH (DE) | 2011-02-22 | — | — | US | disclosed |
| US-20100291622-A1 | NOVEL COMPOUND, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF | SCHOOL JURIDICAL PERSON KITASATO INSTITUTE (JP) | 2010-11-18 | — | — | US | disclosed |
| EP-2236140-A1 | Regulation of phospholipase D activity | The Brigham and Women's Hospital, Inc. (US) | 2010-10-06 | — | — | EP | disclosed |
| EP-2236140-A1 | Regulation of phospholipase D activity | The Brigham and Women's Hospital, Inc. (US) | 2010-10-06 | — | — | EP | disclosed |
| US-20100247522-A1 | LINKED PURINE PTERIN HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS | THE GOV. OF THE U.S.A AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH AND HUMAN SERVICES | 2010-09-30 | — | — | US | disclosed |
| US-20100240871-A1 | Galactose Alpha(1-3) Galactose Compositions | RAJU T SHANTHA | 2010-09-23 | — | — | US | disclosed |
| EP-2230249-A2 | Antigen/antibody or ligand/receptor glycosylated specificity exchangers | ChronTech Pharma AB (SE) | 2010-09-22 | — | — | EP | disclosed |
| US-20100226975-A1 | Compositions and Methods for Stabilizing Lipid Based Adjuvant Formulations Using Glycolipids | STATENS SERUM INSTITUT (DK) | 2010-09-09 | — | — | US | disclosed |
| US-20100204184-A1 | Phosphonates useful as modulators of T-gamma-9-delta-2 activity | LABORATOIRES MAYOLY SPINDLER (FR) | 2010-08-12 | — | — | US | disclosed |
| US-20100183635-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS | TRIPEP AB (SE) | 2010-07-22 | — | — | US | disclosed |
| US-7749520-B2 | Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids | STATENS SERUM INSTITUT (DK) | 2010-07-06 | — | — | US | disclosed |
| EP-2194140-A2 | Process for the production of fine chemicals | Metanomics GmbH (DE) | 2010-06-09 | — | — | EP | disclosed |
| US-20100129383-A1 | BIFUNCTIONAL FUSION MOLECULES FOR THE DELIVERY OF ANTIGENS TO PROFESSIONAL ANTIGEN-PRESENTING CELLS | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2010-05-27 | — | — | US | disclosed |
| WO-2010054654-A1 | MODIFIED CATIONIC LIPOSOME ADJUVANS | STATENS SERUM INSTITUT (DK) | 2010-05-20 | — | — | WO | disclosed |
| WO-2010051227-A1 | GALACTOSE ALPHA (1-3) GALACTOSE COMPOSITIONS | CENTOCOR ORTHO BIOTECH INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| EP-1162976-B1 | 16-PHENOXY-LIPOXIN ANALOGS FOR MEDICAL USE | BRIGHAM & WOMENS HOSPITAL (US) | 2010-05-05 | — | — | EP | disclosed |
| EP-1162976-B1 | 16-PHENOXY-LIPOXIN ANALOGS FOR MEDICAL USE | BRIGHAM & WOMENS HOSPITAL (US) | 2010-05-05 | — | — | EP | disclosed |
| US-20100047828-A1 | SOLID-PHASE DETECTION OF TERMINAL MONOSACCHARIDES CLEAVED FROM GLYCOSYLATED SUBSTRATES | MERCK PATENT GESELLSCHAFT (DE) | 2010-02-25 | — | — | US | disclosed |
| WO-2010009392-A2 | COMPOSITIONS AND METHODS FOR INCREASING MICROBIAL PRODUCTION OF COENZYME Q | OCEAN NUTRITION CANADA LIMITED (CA) | 2010-01-21 | — | — | WO | disclosed |
| US-20090305949-A1 | GLYCOSYLATED SPECIFICITY EXCHANGER | TRIPEP AB (SE) | 2009-12-10 | — | — | US | disclosed |
| EP-1268746-B1 | PRODUCTION OF TcR GAMMA DELTA T CELLS | THERAPURE BIOPHARMA INC (CA) | 2009-11-18 | — | — | EP | disclosed |
| EP-2096177-A2 | Process for the production of lutein | Metanomics GmbH (DE) | 2009-09-02 | — | — | EP | disclosed |
| EP-1846765-B1 | SOLID-PHASE OLIGOSACCHARIDE TAGGING: A TECHNIQUE FOR MANIPULATION OF IMMOBILIZED CARBOHYDRATES | MERCK PATENT GMBH (DE) | 2009-05-27 | — | — | EP | disclosed |
| US-7534435-B2 | Glycosylated specificity exchangers | TRIPEP AB (SE) | 2009-05-19 | — | — | US | disclosed |
| WO-2009061739-A1 | NEUTRALIZATION OF HCV | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2009-05-14 | — | — | WO | disclosed |
| EP-2056842-A2 | MODIFIED -GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS | The Scrips Research Institute (US) | 2009-05-13 | — | — | EP | disclosed |
| EP-2052250-A1 | SOLID-PHASE DETECTION OF TERMINAL MONOSACCHARIDES CLEAVED FROM GLYCOSYLATED SUBSTRATES | MERCK PATENT GmbH (DE) | 2009-04-29 | — | — | EP | disclosed |
| US-20090092631-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS THAT INDUCE AN ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) RESPONSE | TRIPEP AB (SE) | 2009-04-09 | — | — | US | disclosed |
| US-20090047299-A1 | MODIFIED ALPHA-GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-02-19 | — | — | US | disclosed |
| US-20080279894-A1 | Stimulating immunology response; vaccine efficiency; therapy for infections, drug resistant tumors; anticancer agents; autoimmune disease; antiallergens; activation natural killer cells using complex of glycolipid and CD-1 antigen presenting cell | BRIGHAM YOUNG UNIVERSITY (US) | 2008-11-13 | — | — | US | disclosed |
| EP-1974049-A2 | PROCESS FOR THE CONTROL OF PRODUCTION OF FINE CHEMICALS | Metanomics GmbH (DE) | 2008-10-01 | — | — | EP | disclosed |
| US-20080227092-A1 | Solid-Phase Oligosaccharide Tagging: a Technique for Manipulation of Immobilized Carbohydrates | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-18 | — | — | US | disclosed |
| EP-1765289-B1 | COMPOSITIONS AND METHODS FOR STABILIZING LIPID BASED ADJUVANT FORMULATIONS USING GLYCOLIPIDS | STATENS SERUMINSTITUT (DK) | 2008-09-03 | — | — | EP | disclosed |
| WO-2008034575-A1 | IMINOSUGAR GLYCOCONJUGATES | TECHNISCHE UNIVERSITÄT GRAZ (AT) | 2008-03-27 | — | — | WO | disclosed |
| EP-1903034-A1 | Iminosugar glycoconjugates | Technische Universität Graz (AT) | 2008-03-26 | — | — | EP | disclosed |
| US-20080064751-A1 | Regulation of Phospholipase D Activity | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2008-03-13 | — | — | US | disclosed |
| US-20080064751-A1 | Regulation of Phospholipase D Activity | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2008-03-13 | — | — | US | disclosed |
| US-7335359-B2 | Glycosylated specificity exchangers | TRIPEP AB (SE) | 2008-02-26 | — | — | US | disclosed |
| US-7332166-B2 | Glycosylated specificity exchangers | TRIPEP AB (SE) | 2008-02-19 | — | — | US | disclosed |
| WO-2008006373-A1 | SOLID-PHASE DETECTION OF TERMINAL MONOSACCHARIDES CLEAVED FROM GLYCOSYLATED SUBSTRATES | MERCK PATENT GMBH (DE) | 2008-01-17 | — | — | WO | disclosed |
| US-7318926-B2 | Glycosylated specificity exchangers | TRIPEP AB (SE) | 2008-01-15 | — | — | US | disclosed |
| EP-1871883-A1 | PROCESS FOR THE PRODUCTION OF FINE CHEMICALS | Metanomics GmbH (DE) | 2008-01-02 | — | — | EP | disclosed |
| EP-1846765-A1 | SOLID-PHASE OLIGOSACCHARIDE TAGGING: A TECHNIQUE FOR MANIPULATION OF IMMOBILIZED CARBOHYDRATES | Carlsberg A/S (DK) | 2007-10-24 | — | — | EP | disclosed |
| WO-2007118234-A2 | MODIFIED -GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-10-18 | — | — | WO | disclosed |
| US-20070118916-A1 | Process for the production of fine chemicals | METANOMICS GMBH (DE) | 2007-05-24 | — | — | US | disclosed |
| EP-1765857-A2 | PROCESS FOR THE PRODUCTION OF FINE CHEMICALS | Metanomics GmbH (DE) | 2007-03-28 | — | — | EP | disclosed |
| EP-1765289-A2 | COMPOSITIONS AND METHODS FOR STABILIZING LIPID BASED ADJUVANT FORMULATIONS USING GLYCOLIPIDS | Statens Serum Institut (DK) | 2007-03-28 | — | — | EP | disclosed |
| US-20060276621-A1 | Glycosylated specificity exchangers | Knobbe, Martens, Olson & Bear, LLP | 2006-12-07 | — | — | US | disclosed |
| US-20060241087-A1 | Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity | MONTERO JEAN-LOUIS | 2006-10-26 | — | — | US | disclosed |
| WO-2006092449-A2 | PROCESS FOR THE PRODUCTION OF FINE CHEMICALS | METANOMICS GMBH (DE) | 2006-09-08 | — | — | WO | disclosed |
| US-20060194247-A1 | Glycosylated specificity exchangers | Knobbe, Martens, Olson & Bear, LLP | 2006-08-31 | — | — | US | disclosed |
| WO-2006084461-A1 | SOLID-PHASE OLIGOSACCHARIDE TAGGING: A TECHNIQUE FOR MANIPULATION OF IMMOBILIZED CARBOHYDRATES | MERCK PATENT GMBH (DE) | 2006-08-17 | — | — | WO | disclosed |
| US-20060053500-A1 | Modification of sugar metabolic processes in transgenic cells, tissues and animals | Univ. of Pittsburgh of the Commonwealth System of Higher Education, Office of Technology Management (US) | 2006-03-09 | — | — | US | disclosed |
| WO-2006002642-A2 | COMPOSITIONS AND METHODS FOR STABILIZING LIPID BASED ADJUVANT FORMULATIONS USING GLYCOLIPIDS | STATENS SERUM INSTITUT (DK) | 2006-01-12 | — | — | WO | disclosed |
| US-20060008519-A1 | Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids | STATENS SERUM INSTITUT (DK) | 2006-01-12 | — | — | US | disclosed |
| CN-1709894-A | Method for synthesizing polypren phosphate | FORESTRY CHEMISTRY IND INST CH (CN) | 2005-12-21 | — | — | CN | disclosed |
| WO-2005117576-A2 | MODIFICATION OF SUGAR METABOLIC PROCESS IN TRANSGENIC CELLS, TISSUES AND ANIMALS | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2005-12-15 | — | — | WO | disclosed |
| EP-1594898-A2 | GLYCOSYLATED SPECIFICITY EXCHANGERS | Tripep AB (SE) | 2005-11-16 | — | — | EP | disclosed |
| US-20050187294-A1 | Regulation of phospholipase D activity | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2005-08-25 | — | — | US | disclosed |
| US-20050187294-A1 | Regulation of phospholipase D activity | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2005-08-25 | — | — | US | disclosed |
| US-6927238-B2 | Regulation of phospholipase D activity | THE BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 2005-08-09 | — | — | US | disclosed |
| US-6927238-B2 | Regulation of phospholipase D activity | THE BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050074854-A1 | Glycosylated specificity exchangers | Knobbe, Martens, Olson & Bear, LLP | 2005-04-07 | — | — | US | disclosed |
| US-6864288-B2 | Regulation of phospholipase D activity | BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 2005-03-08 | — | — | US | disclosed |
| US-6864288-B2 | Regulation of phospholipase D activity | BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 2005-03-08 | — | — | US | disclosed |
| US-20050019333-A1 | Glycosylated specificity exchangers | Knobbe, Martens, Olson & Bear, LLP | 2005-01-27 | — | — | US | disclosed |
| WO-2004069873-A2 | ANTIGEN/ANTIBODY OR LIGAND/RECEPTOR GLYCOSYLATED SPECIFICITY EXCHANGERS | TRIPEP AB (SE) | 2004-08-19 | — | — | WO | disclosed |
| US-20030157060-A1 | Culture product; interleukins; modulate immunology response; anticancer agents; infection therapy | THERAPURE BIOPHARMA INC. (CA) | 2003-08-21 | — | — | US | disclosed |
| EP-1005564-A4 | PRODUCTION OF NON-NATIVE BACTERIAL EXOPOLYSACCHARIDE IN A RECOMBINANT BACTERIAL HOST | SHINETSU BIO INC (US) | 2003-04-23 | — | — | EP | disclosed |
| US-6537812-B1 | Novel culture method for expanding subset populations of T lymphocytes in the absence of exogenous antigen; use in experimental, therapeutic and commercial applications | HEMOSOL INC. (CA) | 2003-03-25 | — | — | US | disclosed |
| EP-1268746-A2 | PRODUCTION OF TcR GAMMA DELTA T CELLS | Hemosol Inc. (CA) | 2003-01-02 | — | — | EP | disclosed |
| US-20020120013-A1 | Regulation of phospholipase D activity | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-08-29 | — | — | US | disclosed |
| US-20020120013-A1 | Regulation of phospholipase D activity | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-08-29 | — | — | US | disclosed |
| US-20020107289-A1 | Regulation of phospholipase D activity | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-08-08 | — | — | US | disclosed |
| US-20020107289-A1 | Regulation of phospholipase D activity | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-08-08 | — | — | US | disclosed |
| US-20020094549-A1 | Screening methods for presqualene diphosphate analogs | SERHAN CHARLES N (US) | 2002-07-18 | — | — | US | disclosed |
| US-6416965-B2 | COMBINING COMPOUND WITH PHOSPHOLIPASE D(PLD), TREATING MIXTURE WITH PHOSPHATIDYLCHOLINE SO THAT CLEAVAGE REACTION BETWEEN PHOSPHATIDYLCHOLINE AND PLD CAN OCCUR, RESULTING IN GENERATION OF PHOSPHATIDIC ACID AND CHOLINE, EVALUATING AMOUNT OF CHOLINE | BRIGHAM AND WOMEN'S HOSPITAL | 2002-07-09 | — | — | US | disclosed |
| US-6353026-B1 | ANTIINFLAMMATORY AGENTS WITH POLYMORPHONE NEUTROPHILS | BRIGHAM AND WOMEN'S HOSPITAL | 2002-03-05 | — | — | US | disclosed |
| US-6353026-B1 | ANTIINFLAMMATORY AGENTS WITH POLYMORPHONE NEUTROPHILS | BRIGHAM AND WOMEN'S HOSPITAL | 2002-03-05 | — | — | US | disclosed |
| EP-1162976-A2 | REGULATION OF PHOSPHOLIPASE D ACTIVITY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-1162976-A2 | REGULATION OF PHOSPHOLIPASE D ACTIVITY | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000054761-A9 | REGULATION OF PHOSPHOLIPASE D ACTIVITY | BRIGHAM & WOMENS HOSPITAL (US) | 2001-10-25 | — | — | WO | disclosed |
| WO-2000054761-A9 | REGULATION OF PHOSPHOLIPASE D ACTIVITY | BRIGHAM & WOMENS HOSPITAL (US) | 2001-10-25 | — | — | WO | disclosed |
| WO-2001075072-A2 | PRODUCTION OF TcR GAMMA DELTA T CELLS | HEMOSOL INC. (CA) | 2001-10-11 | — | — | WO | disclosed |
| US-6251622-B1 | TREATING OR PREVENTING LEUKOCYTE-MEDIATED INJURY OR INFLAMMATORY RESPONSE BY ADMINISTERING FARNESYL DIPOHSPHATE, PRESQUALENE DIPHOSPHATE, FARNESYL MONOPHOSPHATE, PRESQUALENE MONOPHOSPHATE OR PRESQUALENE DIPHOSPHATE ANALOG | BRIGHAM & WOMEN'S HOSPITAL | 2001-06-26 | — | — | US | disclosed |
| US-20010001062-A1 | Screening methods for presqualene diphosphate analogs | BRIGHAM & WOMEN'S HOSPITAL | 2001-05-10 | — | — | US | disclosed |
| WO-2000054761-A3 | REGULATION OF PHOSPHOLIPASE D ACTIVITY | BRIGHAM & WOMENS HOSPITAL (US) | 2001-03-29 | — | — | WO | disclosed |
| WO-2000054761-A2 | REGULATION OF PHOSPHOLIPASE D ACTIVITY | BRIGHAM AND WOMEN'S HOSPITAL (US) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000054761-A2 | REGULATION OF PHOSPHOLIPASE D ACTIVITY | BRIGHAM AND WOMEN'S HOSPITAL (US) | 2000-09-21 | — | — | WO | disclosed |
| EP-1005564-A1 | PRODUCTION OF NON-NATIVE BACTERIAL EXOPOLYSACCHARIDE IN A RECOMBINANT BACTERIAL HOST | SHIN-ETSU BIO, Inc. (US) | 2000-06-07 | — | — | EP | disclosed |
| US-6066466-A | Screening methods for presqualene diphosphate analogs | BRIGHAM & WOMENS HOSPITAL (US) | 2000-05-23 | — | — | US | disclosed |
| US-6030817-A | TRANSFERRING PORTION OF THE GENOME OF XANTHOMONAS CAMPESTRIS INTO A SPHINGOMONAS SPECIES ENABLING EFFICIENT XANTHAN GUM PRODUCTION | SHIN-ETSU BIO, INC. (US) | 2000-02-29 | — | — | US | disclosed |
| US-6027925-A | MAKING A RECOMBINANT XANTHAN PRODUCING SPHINGOMONAS SPECIES STRAIN BY TRANSFERRING A SPECIFIC SET OF GENES FROM THE GENOME OF XANTHOMONAS CAMPESTRIS INTO THE SPHINGOMONAS SPECIES; PRODUCING XANTHAN GUM FROM LACTOSE | SHIN-ETSU BIO, INC. (US) | 2000-02-22 | — | — | US | disclosed |
| US-6008205-A | Polyisoprenyl phosphate stable analogs for regulation of neutrophil responses | THE BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1998056895-A2 | PRODUCTION OF NON-NATIVE BACTERIAL EXOPOLYSACCHARIDE IN A RECOMBINANT BACTERIAL HOST | SHIN-ETSU BIO, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998056942-A1 | PRODUCTION OF NON-NATIVE BACTERIAL EXOPOLYSACCHARIDE IN A RECOMBINANT BACTERIAL HOST | SHIN-ETSU BIO, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998045466-A1 | COMPOSITIONS AND SCREENING METHODS FOR NEUTROPHIL RESPONSES | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1998-10-15 | — | — | WO | disclosed |
| WO-1998045466-A1 | COMPOSITIONS AND SCREENING METHODS FOR NEUTROPHIL RESPONSES | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1998-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (23 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050019333-A1 | Glycosylated specificity exchangers | SLC17A5, ASGR1, SLC2A1 | BTN3A1 1297/4885FNTA 1256/4885FNTB 1699/4885 |
| US-20120270815-A1 | MODIFIED-GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS | CERS2, UGCG, SGMS1 | BTN3A1 1577/4885FNTA 1222/4885FNTB 1557/4885 |
| US-20060276621-A1 | Glycosylated specificity exchangers | SLC17A5, ASGR1, SLC2A1 | BTN3A1 1297/4885FNTA 1256/4885FNTB 1699/4885 |
| US-20050074854-A1 | Glycosylated specificity exchangers | SLC17A5, ASGR1, SLC2A1 | BTN3A1 1297/4885FNTA 1256/4885FNTB 1699/4885 |
| US-20100204184-A1 | Phosphonates useful as modulators of T-gamma-9-delta-2 activity | CD4, PRKCD, PRKCZ | BTN3A1 417/4885FNTA 902/4885FNTB 556/4885 |
| US-20140081004-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS | SLC17A5, ASGR1, SLC2A1 | BTN3A1 1297/4885FNTA 1256/4885FNTB 1699/4885 |
| US-20080279894-A1 | Stimulating immunology response; vaccine efficiency; therapy for infections, drug resistant tumors; anticancer agents; autoimmune disease; antiallergens; activation natural killer cells using complex of glycolipid and CD-1 antigen presenting cell | CD74, CD4, CD2 | BTN3A1 299/4885FNTA 1424/4885FNTB 914/4885 |
| US-20210285016-A1 | METHODS OF MAKING AND USING E,Z,E-GERANYLGERANYL DIPHOSPHATE | GGPS1, COASY, FDPS | BTN3A1 4330/4885FNTA 4/4885FNTB 5/4885 |
| US-20090305949-A1 | GLYCOSYLATED SPECIFICITY EXCHANGER | SLC17A5, ASGR1, SLC2A1 | BTN3A1 1312/4885FNTA 1567/4885FNTB 1904/4885 |
| US-20170029454-A1 | NKT CELL LIGANDS AND METHODS OF USE | PBK, CD69, NFATC1 | BTN3A1 1101/4885FNTA 1305/4885FNTB 1867/4885 |
| US-20050187294-A1 | Regulation of phospholipase D activity | PLD1, PLD2, PLCD1 | BTN3A1 3307/4885FNTA 320/4885FNTB 279/4885 |
| US-20090092631-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS THAT INDUCE AN ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) RESPONSE | SLC17A5, ASGR1, FCGR1A | BTN3A1 1544/4885FNTA 1566/4885FNTB 2204/4885 |
| US-20020107289-A1 | Regulation of phospholipase D activity | PLD1, PLD2, PLCD1 | BTN3A1 3307/4885FNTA 320/4885FNTB 279/4885 |
| US-20100240871-A1 | Galactose Alpha(1-3) Galactose Compositions | B3GAT3, ST3GAL3, B4GALT1 | BTN3A1 913/4885FNTA 1332/4885FNTB 1386/4885 |
| US-20020120013-A1 | Regulation of phospholipase D activity | PLD1, PLD2, PLCD1 | BTN3A1 3307/4885FNTA 320/4885FNTB 279/4885 |
| US-20080064751-A1 | Regulation of Phospholipase D Activity | PLD1, PLD2, PLCD1 | BTN3A1 3307/4885FNTA 320/4885FNTB 279/4885 |
| US-20100183635-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS | SLC17A5, ASGR1, SLC2A1 | BTN3A1 1297/4885FNTA 1256/4885FNTB 1699/4885 |
| US-12146177-B2 | Methods of making and using E,Z,E-geranylgeranyl diphosphate | GGPS1, COASY, FDPS | BTN3A1 4330/4885FNTA 4/4885FNTB 5/4885 |
| US-20130041131-A1 | GLYCOSYLATED SPECIFICITY EXCHANGERS | SLC17A5, ASGR1, SLC2A1 | BTN3A1 1297/4885FNTA 1256/4885FNTB 1699/4885 |
| US-20090047299-A1 | MODIFIED ALPHA-GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS | CERS2, UGCG, SGMS1 | BTN3A1 1167/4885FNTA 1175/4885FNTB 1132/4885 |
| US-20100291622-A1 | NOVEL COMPOUND, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF | FDPS, GGPS1, FDFT1 | BTN3A1 3788/4885FNTA 19/4885FNTB 15/4885 |
| US-20060241087-A1 | Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity | CD4, GNG2, PLCG2 | BTN3A1 797/4885FNTA 885/4885FNTB 1357/4885 |
| US-20070118916-A1 | Process for the production of fine chemicals | POLRMT, POLI, POLM | BTN3A1 2834/4885FNTA 611/4885FNTB 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.